Clyde W Yancy

Summary

Affiliation: Baylor University Medical Center
Country: USA

Publications

  1. doi request reprint Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial
    Clyde W Yancy
    Baylor University Medical Center, Heart and Vascular Institute, Dallas, TX 75246, USA
    Circ Heart Fail 1:9-16. 2008
  2. ncbi request reprint Race-based therapeutics
    Clyde W Yancy
    3500 Gaston Avenue, Suite H 030, Dallas, TX 75246, USA
    Curr Hypertens Rep 10:276-85. 2008
  3. doi request reprint Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry
    Clyde W Yancy
    Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas 75246, USA
    J Am Coll Cardiol 51:1675-84. 2008
  4. ncbi request reprint Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure
    Clyde W Yancy
    Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas 75246, USA
    Drug Saf 30:765-81. 2007
  5. doi request reprint Adherence to guideline-recommended adjunctive heart failure therapies among outpatient cardiology practices (findings from IMPROVE HF)
    Clyde W Yancy
    Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas, USA
    Am J Cardiol 105:255-60. 2010
  6. pmc Executive summary of the African-American Initiative
    Clyde W Yancy
    Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas, USA
    MedGenMed 9:28. 2007
  7. ncbi request reprint The Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial for advanced heart failure: study rationale and design
    Clyde W Yancy
    Baylor University Medical Center, Heart and Vascular Institute, Dallas, TX 75246, USA
    Am Heart J 153:478-84. 2007
  8. ncbi request reprint B-type natriuretic peptides in management of acute decompensated heart failure
    Clyde W Yancy
    Baylor University Medical Center, Dallas, TX, USA
    Heart Fail Clin 2:353-64. 2006
  9. doi request reprint Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF
    Clyde W Yancy
    Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX 75246, USA
    Am Heart J 157:754-62.e2. 2009
  10. ncbi request reprint Heart failure in African Americans
    Clyde W Yancy
    Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9047, USA
    Am J Cardiol 96:3i-12i. 2005

Detail Information

Publications93

  1. doi request reprint Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial
    Clyde W Yancy
    Baylor University Medical Center, Heart and Vascular Institute, Dallas, TX 75246, USA
    Circ Heart Fail 1:9-16. 2008
    ..Nesiritide relieves dyspnea and reduces pulmonary congestion, but its risk profile is uncertain. Pilot data suggested a potential benefit of nesiritide given as serial outpatient infusions...
  2. ncbi request reprint Race-based therapeutics
    Clyde W Yancy
    3500 Gaston Avenue, Suite H 030, Dallas, TX 75246, USA
    Curr Hypertens Rep 10:276-85. 2008
    ..As more physiologic markers of disease and drug responsiveness become available, the need for racial designations in medicine may lessen, and therapies can be optimized for all patients without regard to race or ethnicity...
  3. doi request reprint Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry
    Clyde W Yancy
    Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas 75246, USA
    J Am Coll Cardiol 51:1675-84. 2008
    ..We sought to examine the characteristics, quality of care, and clinical outcomes for a large cohort of African-American patients hospitalized with heart failure (HF) in centers participating in a quality improvement initiative...
  4. ncbi request reprint Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure
    Clyde W Yancy
    Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas 75246, USA
    Drug Saf 30:765-81. 2007
    ..When used for approved indications and according to recommended dosage and administration regimens, nesiritide represents a reasonable treatment adjunct for ADHF...
  5. doi request reprint Adherence to guideline-recommended adjunctive heart failure therapies among outpatient cardiology practices (findings from IMPROVE HF)
    Clyde W Yancy
    Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas, USA
    Am J Cardiol 105:255-60. 2010
    ..In conclusion, improved processes of care, better documentation, and/or increased measures to promote adherence to all primary and adjunctive therapies for HF are needed...
  6. pmc Executive summary of the African-American Initiative
    Clyde W Yancy
    Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas, USA
    MedGenMed 9:28. 2007
    ....
  7. ncbi request reprint The Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial for advanced heart failure: study rationale and design
    Clyde W Yancy
    Baylor University Medical Center, Heart and Vascular Institute, Dallas, TX 75246, USA
    Am Heart J 153:478-84. 2007
    ..Within a prespecified subset of high-risk patients, a potential signal of benefit on a combined end point of mortality and cardiovascular hospitalization was identified...
  8. ncbi request reprint B-type natriuretic peptides in management of acute decompensated heart failure
    Clyde W Yancy
    Baylor University Medical Center, Dallas, TX, USA
    Heart Fail Clin 2:353-64. 2006
  9. doi request reprint Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF
    Clyde W Yancy
    Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX 75246, USA
    Am Heart J 157:754-62.e2. 2009
    ....
  10. ncbi request reprint Heart failure in African Americans
    Clyde W Yancy
    Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9047, USA
    Am J Cardiol 96:3i-12i. 2005
    ..This review discusses the unique characteristics of CVD in African Americans and addresses the need for targeted treatments to reduce the excess burden found in this population...
  11. ncbi request reprint The prevention of heart failure in minority communities and discrepancies in health care delivery systems
    Clyde W Yancy
    The University of Texas Southwestern Medical Center, Dallas, TX 75390 9047, USA
    Med Clin North Am 88:1347-68, xii-xiii. 2004
    ..Treatment regimens should be individualized based on the disease presentation, associated comorbidity, and disease severity and not on something as arbitrary as race...
  12. doi request reprint Characteristics and outcomes in African American patients with decompensated heart failure
    Sandeep A Kamath
    University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Arch Intern Med 168:1152-8. 2008
    ..Therefore, we assessed race-related differences in presentation, treatment, in-patient experiences, and short-term mortality due to ADHF before and after accounting for known covariates...
  13. ncbi request reprint Quality of care and outcomes in acute decompensated heart failure: The ADHERE Registry
    Clyde W Yancy
    University of Texas Southwestern Medical Center, Division of Cardiology, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    Curr Heart Fail Rep 1:121-8. 2004
    ..These patient data have been reviewed and reveal important findings regarding acute decompensated heart failure and potential opportunities to improve the quality of care...
  14. ncbi request reprint Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insufficiency (from the Follow-Up Serial Infusions of Nesiritide [FUSION I] trial)
    Clyde W Yancy
    Department of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas, and Renal Division, Brigham and Women s Hospital, Boston, MA, USA
    Am J Cardiol 98:226-9. 2006
    ..Further study is warranted to test the validity of this finding...
  15. ncbi request reprint Effects of early steroid withdrawal after heart transplantation
    David H Rosenbaum
    Department of Cardiovascular and Thoracic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Ann Thorac Surg 82:637-44; discussion 644. 2006
    ..We returned to this group of patients to investigate the long-term effects of our steroid taper protocol...
  16. doi request reprint Concentric left ventricular hypertrophy as assessed by cardiac magnetic resonance imaging and risk of death in cardiac transplant recipients
    Parag C Patel
    Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
    J Heart Lung Transplant 29:1369-79. 2010
    ..We determined whether increased LV mass and concentricity (mass/volume) were associated with death in patients after HTx...
  17. ncbi request reprint The editor's roundtable: Acute decompensated heart failure
    Vincent E Friedewald
    Department of Internal Medicine, The University of Texas Medical School at Houston, Texas, USA
    Am J Cardiol 99:1560-7. 2007
  18. doi request reprint The Editor's Roundtable: Endothelial dysfunction in cardiovascular disease
    Vincent E Friedewald
    Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, Texas, USA
    Am J Cardiol 102:418-23. 2008
  19. pmc Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure
    Melvin R Echols
    University of Texas Southwestern Dallas, TX, USA
    Vasc Health Risk Manag 2:423-31. 2006
    ..These findings strongly imply that nitric oxide enhancement and/or oxidative stress reduction may be important new therapeutic directions in the management of heart failure...
  20. ncbi request reprint Evidence for the continued safety and tolerability of fixed-dose isosorbide dinitrate/hydralazine in patients with chronic heart failure (the extension to African-American Heart Failure Trial)
    Clyde W Yancy
    Baylor University Medical Center, Heart and Vascular Institute, Dallas, Texas, USA
    Am J Cardiol 100:684-9. 2007
    ..In conclusion, these results confirm the good compliance, tolerability, and responsiveness, with low mortality and improved symptoms, during treatment with ID/H observed in A-HeFT...
  21. doi request reprint Blacks and whites have a similar prevalence of reduced left ventricular ejection fraction in the general population: the Dallas Heart Study (DHS)
    David W Markham
    Donald W Reynolds Cardiovascular Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, TX 75390 9047, USA
    Am Heart J 155:876-82. 2008
    ..Because of the higher prevalence of risk factors for heart failure in blacks, including hypertension, obesity, and LV hypertrophy, we hypothesized that LV dysfunction would also be more common in this ethnic group...
  22. ncbi request reprint Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure
    Milton Packer
    University of Texas Southwestern Medical Center, Dallas, Texas 75390 8822, USA
    J Am Coll Cardiol 47:2245-52. 2006
    ..This study sought to assess the potential utility of impedance cardiography (ICG) in predicting clinical deterioration in ambulatory patients with heart failure (HF)...
  23. doi request reprint The editor's roundtable: B-type natriuretic peptide
    Vincent E Friedewald
    Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, Texas, USA
    Am J Cardiol 101:1733-40. 2008
  24. ncbi request reprint Decompensated heart failure: is there a role for the outpatient use of nesiritide?
    Clyde W Yancy
    University of Texas Southwestern Medical Center, Department of Internal Medicine Cardiology Division, CS7 102, 5323 Harry Hines Boulevard, Dallas, TX 75235, USA
    Congest Heart Fail 10:230-6. 2004
    ..Such an approach, once validated, should be integrated into an evidence-based HF disease management program...
  25. doi request reprint Clinical outcomes after cardiac transplantation in muscular dystrophy patients
    Roland S Wu
    Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390 8573, USA
    J Heart Lung Transplant 29:432-8. 2010
    ..Patients with muscular dystrophy are at risk of developing a dilated cardiomyopathy and can progress to advanced heart failure. At present, it is not known whether such patients can safely undergo cardiac transplantation...
  26. ncbi request reprint Racial response to angiotensin-converting enzyme therapy in systolic heart failure
    Daniel J Dries
    Donald W Reynolds Cardiovascular Clinical Research Center, Room H8 116, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    Congest Heart Fail 10:30-3. 2004
    ..Race is an inadequate model to explain the observed differences. Careful translational research focusing on genetic patterns of disease may help resolve these outstanding questions...
  27. ncbi request reprint Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database
    Clyde W Yancy
    Division of Cardiology, Department of Medicine, University of Texas Southwest Medical Center, Dallas, Texas 75390 9047, USA
    J Am Coll Cardiol 47:76-84. 2006
    ..Medical treatment strategies for patients with preserved systolic function are inconsistent and reflect the need for efficacious evidence-based treatment regimens...
  28. ncbi request reprint Current approaches to monitoring and management of heart failure
    Clyde W Yancy
    Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA
    Rev Cardiovasc Med 7:S25-32. 2006
    ..When combined with clinical assessment, weight monitoring, and symptom assessment, these newer monitoring platforms may yield improvements in the natural history of heart failure...
  29. ncbi request reprint Treatment with B-type natriuretic peptide for chronic decompensated heart failure: insights learned from the follow-up serial infusion of nesiritide (FUSION) trial
    Clyde W Yancy
    University of Texas Southwestern Medical Center, Dallas, TX, USA
    Heart Fail Rev 9:209-16. 2004
    ..If positive data emerge from FUSION II that either confirm or strengthen the data in FUSION I, a new therapeutic option may be available for patients with chronic decompensated heart failure...
  30. ncbi request reprint The use of beta-adrenergic receptor antagonists in the treatment of African Americans with heart failure
    Clyde W Yancy
    University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 9047, USA
    Congest Heart Fail 10:34-7. 2004
    ..The first prospective trial in African Americans with heart failure, the African American Heart Failure Trial (A-HeFT), is ongoing and provides additional insight into the best treatment strategies for this patient population...
  31. ncbi request reprint Special considerations for carvedilol use in heart failure
    Clyde W Yancy
    University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
    Am J Cardiol 93:64B-8B. 2004
    ....
  32. ncbi request reprint Relation of lower hematocrit to progression from asymptomatic left ventricular dysfunction to symptomatic heart failure (from the Studies of Left Ventricular Dysfunction Prevention trial)
    Sandeep R Das
    Donald W Reynolds Cardiovascular Clinical Research Center, Dallas, Texas, USA
    Am J Cardiol 96:827-31. 2005
    ..37 to 2.34), first HF hospitalization (HR 2.35, 95% CI 1.52 to 3.62), and death or the development of HF symptoms (HR 1.60, 95% CI 1.28 to 1.99) compared with patients in the highest hematocrit quartile (hematocrit > 46%)...
  33. ncbi request reprint Heart failure in African Americans: pathophysiology and treatment
    Clyde W Yancy
    Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas, TX 75390 9047, USA
    J Card Fail 9:S210-5. 2003
  34. ncbi request reprint The role of race in heart failure therapy
    Clyde W Yancy
    Department of Internal Medicine Cardiology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    Curr Cardiol Rep 4:218-25. 2002
    ..Certain genetic polymorphisms may exist that explain the observed differences...
  35. ncbi request reprint Cardiovascular disease in African Americans
    Clyde W Yancy
    University of Texas Southwestern Medical Center, Department of Internal Medicine Cardiology Division, CS7 102, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    J Clin Hypertens (Greenwich) 6:54-6. 2004
  36. ncbi request reprint Antibodies against donor human leukocyte antigens and the outcome of cardiac allografts in adults and children
    Peter Stastny
    Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390 8886, USA
    Transplantation 84:738-45. 2007
    ..Antibodies against human leukocyte antigen (HLA) are known to appear in the serum of heart transplant recipients...
  37. pmc Correlation of impedance cardiography with invasive hemodynamic measurements in patients with advanced heart failure: the BioImpedance CardioGraphy (BIG) substudy of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Eff
    Sandeep A Kamath
    University of Texas Southwestern Medical Center, Dallas, TX 75390 9047, USA
    Am Heart J 158:217-23. 2009
    ..The utility of ICG in patients hospitalized with heart failure is uncertain...
  38. doi request reprint Systolic time ratio by impedance cardiography to distinguish preserved vs impaired left ventricular systolic function in heart failure
    Brenda Thompson
    Cardiovascular Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390 9200, USA
    Congest Heart Fail 14:261-5. 2008
    ..50 demonstrated 93% sensitivity and 85% specificity. STR was able to distinguish intact (>50%) from impaired EF (< or =50%). STR by ICG has the potential to be a reliable method to monitor ventricular function in chronic HF...
  39. ncbi request reprint Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: a retrospective analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Prevention trial
    Sandeep R Das
    Donald W Reynolds Cardiovascular Clinical Research Center, Division of Cardiology, University of Texas Southwestern Medical School, Dallas, Tex, USA
    Am Heart J 148:883-8. 2004
    ..Whether diabetes mellitus is a risk factor for the progression from asymptomatic left ventricular systolic dysfunction to symptomatic heart failure in patients with left ventricular dysfunction of an ischemic cause is not known...
  40. ncbi request reprint Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial)
    Clyde W Yancy
    University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Am J Cardiol 94:595-601. 2004
    ..Additional studies are needed to determine the effect of outpatient serial infusions of nesiritide on rates of morbidity and mortality in advanced heart failure...
  41. ncbi request reprint The natural history, epidemiology, and prognosis of heart failure in African Americans
    Clyde W Yancy
    University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    Congest Heart Fail 10:15-8; quiz 21-2. 2004
    ..An increased awareness of the risk of hypertension followed by early and effective intervention may reduce the risk of heart failure in this population...
  42. ncbi request reprint Routine computed tomography screening of the chest in high-risk cardiac transplant recipients may improve survival
    David H Rosenbaum
    Department of Thoracic and Cardiovascular Surgery, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 8879, USA
    J Heart Lung Transplant 24:2043-7. 2005
    ..We reviewed our cardiac transplantation experience with respect to the development of bronchogenic carcinoma and explored the role of routine chest computed tomography (CT) in its surveillance...
  43. ncbi request reprint Introduction: heart failure in African Americans
    Clyde W Yancy
    University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    Congest Heart Fail 10:12. 2004
  44. ncbi request reprint Beta-blocker therapy in patients with heart failure in the urban setting: moving beyond clinical trials
    Jerry D Estep
    Heart Failure Research Unit, Dallas, Tex, USA
    Am Heart J 148:958-63. 2004
    ..We wanted to identify patient characteristics that could guide primary care physicians in deciding whether they or a cardiologist should initiate BBL. A second objective was to determine the tolerability of BBL in clinical practice...
  45. ncbi request reprint Comprehensive treatment of heart failure: state-of-the-art medical therapy
    Clyde W Yancy
    University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Rev Cardiovasc Med 6:S43-57. 2005
    ....
  46. doi request reprint Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment
    Adam H Miller
    Department of Surgery Division of Emergency Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390 8579, USA
    Ann Emerg Med 51:571-8. 2008
    ..Nesiritide has been demonstrated to relieve symptoms of acutely decompensated congestive heart failure. We examined the effect of an 8-hour infusion of nesiritide on the composite of return to the ED or hospitalization at 30 days...
  47. doi request reprint The coalition to reduce racial and ethnic disparities in cardiovascular disease outcomes (credo): why credo matters to cardiologists
    Clyde W Yancy
    Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas, USA
    J Am Coll Cardiol 57:245-52. 2011
    ..credo will provide the CVD treatment community with greater awareness of disparities and tools to help close the gap in care and outcomes for all patient subpopulations...
  48. ncbi request reprint Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation
    Paul B Rosenberg
    Heart and Lung Transplant Program, St Paul University Hospital, Dallas, Texas, USA
    J Heart Lung Transplant 24:1327-31. 2005
    ....
  49. pmc Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial
    David E Lanfear
    Heart and Vascular Institute, Henry Ford Hospital, Detroit, MI, USA
    Circ Heart Fail 6:47-52. 2013
    ..However, the relationship between baseline and trends in AVP with outcomes in patients hospitalized for worsening heart failure with reduced ejection fraction is unclear...
  50. ncbi request reprint The editor's roundtable: Cardiac resynchronization therapy
    Vincent E Friedewald
    Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, Texas, USA
    Am J Cardiol 100:1145-52. 2007
  51. pmc Heart failure in African Americans: unique etiology and pharmacologic treatment responses
    Clyde W Yancy
    University of Texas, Southwestern Medical Center, Dallas, Texas 75390, USA
    J Natl Med Assoc 95:1-9, quiz 10-2. 2003
    ..Credit may be claimed for one year from date of individual use.Expiration:The quiz must be completed, postmarked and mailed by Feb. 25, 2003, for eligibility to receive continuing medical education credit for this CME activity...
  52. ncbi request reprint Practical considerations for BNP use
    Clyde W Yancy
    UT Southwestern Medical Center, Dallas, TX 75390 9047, USA
    Heart Fail Rev 8:369-73. 2003
    ..New biomarkers for heart failure similar to BNP are on the horizon but their clinical niche has yet to be determined...
  53. ncbi request reprint Special clinical considerations of beta-blocker treatment
    Clyde W Yancy
    Departments of Medicine and Cardiology, Heart Failure Transplantation Services, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Rev Cardiovasc Med 3:S27-35. 2002
    ..Future trials will address these groups in a prospective manner...
  54. ncbi request reprint Summary: Cardiovascular disease in African Americans
    Clyde W Yancy
    University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 9047, USA
    Congest Heart Fail 10:44. 2004
  55. doi request reprint Impact of a standardized heart failure order set on mortality, readmission, and quality and costs of care
    David J Ballard
    Baylor Health Care System, Institute for Health Care Research and Improvement, Dallas, TX 75206, USA
    Int J Qual Health Care 22:437-44. 2010
    ..To determine the impact of a standardized heart failure order set on mortality, readmission, and quality and costs of care...
  56. ncbi request reprint Heart failure therapy in special populations: the same or different?
    Clyde W Yancy
    Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Rev Cardiovasc Med 5:S28-35. 2004
    ..These special populations, however, should receive medical therapy for heart failure that is consistent with the results from the major trials and is in accordance with published heart failure guidelines...
  57. ncbi request reprint Improving outcomes in the post-myocardial infarction setting
    Clyde W Yancy
    University of Texas Southwestern Medical Center, Department of Internal Medicine Cardiology Division, CS7 102, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    J Clin Hypertens (Greenwich) 6:34-41. 2004
    ....
  58. ncbi request reprint Novel therapies for heart failure: vasopressin and selective aldosterone antagonists
    Sandeep A Kamath
    Department of Internal Medicine Cardiology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9047, USA
    Congest Heart Fail 11:21-9. 2005
    ..Whether aldosterone antagonism should be prescribed in all patients with HF is unclear; however, in carefully selected and managed patients, aldosterone antagonism is helpful...
  59. doi request reprint Best clinical trials reported in 2010
    John B Garner
    Baylor University Medical Center Jack and Jane Hamilton Heart Hospital, Baylor Heart and Vascular Institute, Dallas, Texas, USA
    Am J Cardiol 108:162-8. 2011
    ..It is hoped that this compilation of relevant clinical trials and their important findings released in 2010 will be of benefit in the everyday practice of cardiovascular medicine...
  60. ncbi request reprint Health insurance and cardiac transplantation: a call for reform
    Louise P King
    Donald W Reynolds Cardiovascular Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9047, USA
    J Am Coll Cardiol 45:1388-91. 2005
    ..We call for a government-sponsored, multidisciplinary task force to address this situation in hopes of remedying the inequities in the present system of organ allocation...
  61. ncbi request reprint b-Blocker therapy for congestive heart failure: Clinical considerations
    Sandeep A Kamath
    Dallas, TX 75390 9047, USA
    Postgrad Med 118:12-20. 2005
    ....
  62. ncbi request reprint Potential contributing factors to noncompliance with dietary sodium restriction in patients with heart failure
    Jennifer B Neily
    Parkland Memorial Hospital, Donald W Reynolds Cardiovascular Clinical Research Center, Dallas, Tex, USA
    Am Heart J 143:29-33. 2002
    ..Although sodium restriction is considered essential in the management of patients with chronic heart failure (CHF), there are no data available regarding patients awareness of and ability to comply with the sodium restriction guideline...
  63. ncbi request reprint Advances in the management of acute and chronic decompensated heart failure
    Sandra L Lowery
    CCMI Associates, Francestown, NH 03043, USA
    Lippincotts Case Manag 9:4-18; quiz 19-20. 2004
    ..To date the typical treatment of acute decompensation has been based in the hospital and woefully inadequate in promoting any long-term medical stability...
  64. doi request reprint Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program
    Gregg C Fonarow
    Department of Medicine, University of California Los Angeles Medical Center, Los Angeles, California 90095 1679, USA
    J Am Coll Cardiol 52:190-9. 2008
    ..This study ascertains the relationship between continuation or withdrawal of beta-blocker therapy and clinical outcomes in patients hospitalized with systolic heart failure (HF)...
  65. ncbi request reprint Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design
    Gregg C Fonarow
    Department of Medicine, UCLA Medical Center, Los Angeles, Calif, USA
    Am Heart J 148:43-51. 2004
    ..The ultimate aim of this program is to improve the standard of HF care in the hospital and outpatient settings and increase the use of evidence-based therapeutic strategies to save lives...
  66. doi request reprint Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)
    William T Abraham
    Division of Cardiology, The Ohio State University, Columbus, Ohio, USA
    J Am Coll Cardiol 52:347-56. 2008
    ..The aim of this study was to develop a clinical model predictive of in-hospital mortality in a broad hospitalized heart failure (HF) patient population...
  67. ncbi request reprint African-American Heart Failure Trial (A-HeFT): rationale, design, and methodology
    Joseph A Franciosa
    Zena and Michael A Wiener Cardiovascular Institute, Mt Sinai School of Medicine, New York, New York, USA
    J Card Fail 8:128-35. 2002
    ..Analysis of previous trials has shown that H+ISDN appears especially beneficial in African American patients...
  68. ncbi request reprint Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)
    Barry H Greenberg
    University of California San Diego Medical Center, San Diego, CA 92103 8411, USA
    Am Heart J 154:277.e1-8. 2007
    ..Whether diabetes mellitus (DM) influences characteristics and outcomes in patients hospitalized with HF has not been well studied...
  69. ncbi request reprint Advances in the management of acute and chronic decompensated heart failure
    Sandra L Lowery
    CCMI Associates, 1163 New Boston Road, Francestown, NH 03043, USA
    Lippincotts Case Manag 9:S1-15; quiz S16-7. 2004
    ..To date the typical treatment of acute decompensation has been based in the hospital and woefully inadequate in promoting any long-term medical stability...
  70. doi request reprint Pharmacologic therapies across the continuum of left ventricular dysfunction
    William T Abraham
    Division of Cardiovascular Medicine, Ohio State University Medical Center, Columbus, Ohio 43210, USA
    Am J Cardiol 102:21G-28G. 2008
    ..This review illustrates the impact of these therapies on post-MI LVD patients using evidence from multiple clinical trials. In addition, current and emerging treatments for acute decompensated HF will be outlined...
  71. doi request reprint Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)
    CHRISTOPHER M O'CONNOR
    Duke University Medical Center Duke Clinical Research Institute, Durham, NC 27705, USA
    Am Heart J 156:662-73. 2008
    ..We developed clinical models predictive of short-term clinical outcomes in a broad patient population discharged after hospitalization for HF...
  72. pmc Quality of care and outcomes among patients with heart failure and chronic kidney disease: A Get With the Guidelines -- Heart Failure Program study
    Uptal D Patel
    Division of Nephrology, Duke University Medical Center, Durham, NC, USA
    Am Heart J 156:674-81. 2008
    ..Both heart failure (HF) and chronic kidney disease (CKD) are highly prevalent conditions that often coexist; however, the quality of care received by hospitalized patients with both is not known...
  73. ncbi request reprint Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial
    Anne L Taylor
    Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA
    Circulation 115:1747-53. 2007
    ....
  74. doi request reprint Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF
    Gregg C Fonarow
    Department of Medicine, UCLA University of California, Los Angeles Medical Center, Los Angeles, CA 90095 1679, USA
    Arch Intern Med 168:847-54. 2008
    ..This study evaluated the association between precipitating factors identified at the time of HF hospital admission and subsequent clinical outcomes...
  75. ncbi request reprint BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases
    Marc A Silver
    Department of Medicine and Heart Failure Institute, Advocate Christ Medical Center, Oak Lawn, IL 60453 2600, USA
    Congest Heart Fail 10:1-30. 2004
    ..An expert Consensus Panel with basic, methodological, and clinical expertise was convened to summarize current knowledge in these areas and the findings and consensus statements are contained herein...
  76. ncbi request reprint Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE)
    Gregg C Fonarow
    Ahmanson UCLA Cardiomyopathy Center, Los Angeles, CA 90095, USA
    Am Heart J 153:1021-8. 2007
    ..The purpose of this study was to assess temporal trends in clinical characteristics, treatments, quality indicators, and outcomes for heart failure (HF) hospitalizations...
  77. ncbi request reprint Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry
    Gregg C Fonarow
    Department of Medicine, Ahmanson UCLA Cardiomyopathy Center, Los Angeles, CA 90095 1679, USA
    Am Heart J 154:12-38. 2007
    ..Deidentified clinical data from the medical records of a planned 43,000 patients from 160 US cardiology practices will be included in this study...
  78. ncbi request reprint The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart
    Maria Rosa Costanzo
    Midwest Heart Foundation, Lombard, IL, USA
    Am Heart J 154:267-77. 2007
    ..Significant concerns have been expressed regarding risks and benefits of individual therapies, especially nesiritide (NES), but few studies have compared the relative safety of varied intravenous therapies on clinical outcomes...
  79. ncbi request reprint Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF)
    Gregg C Fonarow
    Department of Medicine, University of California Los Angeles Medical Center, 10833 LeConte Ave, Room 47 123 CHS, Los Angeles, CA 90095 1679, USA
    Arch Intern Med 167:1493-502. 2007
    ..We sought to evaluate the effect of a national hospital-based initiative on quality of care in patients hospitalized with HF...
  80. ncbi request reprint Treatment of ventricular dysrhythmias and sudden cardiac death: a guideline-based approach for patients with chronic left ventricular dysfunction
    Ayesha Hasan
    Division of Cardiovascular Medicine, Heart Failure Devices Clinic, Ohio State University College of Medicine, Columbus, OH 43210 1252, USA
    Congest Heart Fail 13:228-35. 2007
    ..In addition, the authors review current guidelines for electrophysiology testing in chronic left ventricular dysfunction and the emerging role of microvolt T-wave alternans as a means of risk stratification...
  81. ncbi request reprint Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry
    Mihai Gheorghiade
    Division of Cardiology, Feinberg School of Medicine, Northwestern University, Galter 10 240, 201 E Huron Street, Chicago, IL 60611, USA
    Eur Heart J 28:980-8. 2007
    ..The predictive value of hyponatraemia has not been evaluated in unselected patients hospitalized with heart failure...
  82. ncbi request reprint Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry
    Gregg C Fonarow
    Ahmanson UCLA Cardiomyopathy Center, Department of Medicine, UCLA Medical Center, Los Angeles, California 90095 1679, USA
    J Am Coll Cardiol 50:768-77. 2007
    ..We sought to evaluate the characteristics, treatments, and outcomes of patients with preserved and reduced systolic function heart failure (HF)...
  83. ncbi request reprint Beyond diuretics: management of volume overload in acute heart failure syndromes
    James A Hill
    Division of Cardiovascular Medicine, University of Florida, Gainesville, Florida, USA
    Am J Med 119:S37-44. 2006
    ....
  84. ncbi request reprint Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure
    Mihai Gheorghiade
    Division of Cardiology, Feinberg School of Medicine, Northwestern University, Chicago, Ill, USA
    JAMA 296:2217-26. 2006
    ..The association between systolic blood pressure (SBP) at admission, clinical characteristics, and outcomes in patients hospitalized for heart failure who have reduced or relatively preserved systolic function has not been well studied...
  85. ncbi request reprint Overview of B-type natriuretic peptide as a blood test. Roundtable discussion
    Peter A McCullough
    Division of Nutrition and Preventive Medicine, William Beaumont Hospital, Royal Oak, MI 48073 1026, USA
    Congest Heart Fail 12:99-102. 2006
    ..Clyde Yancy, Associate Dean for Medical Affairs at the University of Texas Southwestern Medical Center, Dallas, TX, participated in the discussion...
  86. ncbi request reprint Using homeostatic peptides in decompensated heart failure a reasonable paradigm but a flawed practice?
    Marc A Silver
    J Am Coll Cardiol 50:1841-3. 2007
  87. ncbi request reprint Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF
    Gregg C Fonarow
    Department of Medicine, University of California Los Angeles Medical Center, Los Angeles, California 90095 1679, USA
    J Card Fail 13:722-31. 2007
    ..The objective of this study was to prospectively evaluate beta-blocker use at hospital discharge as an indicator of quality of care and outcomes in patients with heart failure (HF)...
  88. ncbi request reprint Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE Registry
    Gregg C Fonarow
    Division of Cardiology, Ahmanson UCLA Cardiomyopathy Center, The David Geffen School of Medicine at University of California, Los Angeles 90095, USA
    Arch Intern Med 165:1469-77. 2005
    ..Quality-of-care indicators have been developed for patients hospitalized with heart failure. However, little is known about current rates of conformity with these indicators or their variability across hospitals...
  89. doi request reprint Cardiorenal interactions: insights from the ESCAPE trial
    Anju Nohria
    Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    J Am Coll Cardiol 51:1268-74. 2008
    ....
  90. pmc Comparison of clinical features and outcomes of patients hospitalized with heart failure and normal ejection fraction (> or =55%) versus those with mildly reduced (40% to 55%) and moderately to severely reduced (<40%) fractions
    Nancy K Sweitzer
    University of Wisconsin, Madison, Wisconsin, USA
    Am J Cardiol 101:1151-6. 2008
    ..These observations may be important considerations in the design of future clinical trials...
  91. ncbi request reprint Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis
    Gregg C Fonarow
    Ahmanson UCLA Cardiomyopathy Center, University of California, Los Angeles Medical Center, Los Angeles, CA 90095, USA
    JAMA 293:572-80. 2005
    ..Estimation of mortality risk in patients hospitalized with acute decompensated heart failure (ADHF) may help clinicians guide care...
  92. doi request reprint Society of Chest Pain Centers Recommendations for the evaluation and management of the observation stay acute heart failure patient: a report from the Society of Chest Pain Centers Acute Heart Failure Committee
    W Frank Peacock
    Crit Pathw Cardiol 7:83-6. 2008
  93. ncbi request reprint Predictors of delivery of hospital-based heart failure patient education: a report from OPTIMIZE-HF
    Nancy M Albert
    Division of Nursing and George M and Linda H Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Card Fail 13:189-98. 2007
    ....